Custom In-House Pharmaceutical Training for Teams
Elevate your team's expertise with our tailored in-house training programs. Designed for pharmaceutical and biotech professionals, we deliver high-impact learning directly to your organization—onsite or virtually—saving you time and travel costs while maximizing relevance.
Why choose our in-house training?
Flexible Onsite or Online Delivery
Train your team at the time and place that works best for you. Whether in your offices or virtually, our pharmaceutical training programs fit around your schedule.
Cost-Efficient Group Solutions
Save on multiple delegate fees and travel expenses by training everyone together. A single program equips your whole department with the same industry-standard knowledge.
Custom Content & Interactive Workshops
Get a curriculum that speaks directly to your projects and challenges. We adapt the agenda, case studies, and exercises to your company's specific pharmaceutical needs.
Expert Pharmaceutical Consulting Sessions
Overcome pharmaceutical development challenges and launch your innovative treatment solutions with our expert consulting. Whether you need guidance on regulatory hurdles, clinical trial optimization, or technical drug development, our team provides tailored advice across the entire product lifecycle.
Helping clients develop cutting-edge new drugs for the worldwide market. Applying latest trends in bioequivalence and dissolution testing to speed up research & development initiatives.
Experts
Dr. Paula Muniz
Dr. Klaus Rensing
Franz Nothelfer
Dr. Malcolm Ross
Ensuring compliance of quality management systems throughout all phases of drug development.
Experts
Dr. Tony Cundell
Dr. Malcolm Ross
Helping companies successfully scale-up manufacturing of biologics, solid dosage forms, injectables and medical devices. Applying best practices in validation and technology transfer to our customer's current goals.
Experts
Dr. Michael Braun
Dr. Samuel Denby
Dr. Laura Butafoco
Jan Harmsen
Navigating clients through the complex regulatory landscape of pharmaceuticals and biologics. Co-creating and co-analyzing clinical trials while focusing on fast-to-patient market access strategy.
Experts
Dr. Karl-Heinz Huemer
Dr. Simon Day
David Schwicker
Dr. Malcolm Ross
Helping clients develop and launch new orphan drugs while staying compliant with the current regulations. Using our orphan drugs market know-how, from both EMA/FDA and industry perspective, to benefit from growing possibilities in rare diseases.
Experts
David Schwicker
Dr. Simon Day
Consulting Case Studies
Biologics Viral Safety Study
A biopharma company attempting to launch a virus clearance of biosimilars study was unsure about their plans for extended Phase I/II study and unable to create Phase III/market study. Thanks to Symmetric's support, the company developed and executed virus clearance study of 3 selected ATMPs in less than 6 months. Discussions and insights about viral clearance reporting to EMA & FDA, design and validation of scale-down models, worst-case parameters and critical process parameters set the team for success.
Patient Centricity in Clinical Development
An orphan-drugs focused pharmaceutical company was struggling to implement patient centricity into their clinical trials development. Symmetric helped the clinical research team apply patient-focused strategies, beyond standard clinical trials. Development of innovative PRO strategies helped this client reduce the usual clinical trial drop-out rate from 30% to just 5%.
Paediatric Clinical Trial Success
A biopharma company was aiming to launch its first paediatric clinical trial. Consulting sessions with one of our experts solved client's most burning issues regarding protocol writing, clinical trial model selection and recruitment of paediatric patients. Moreover, using our global networks, we helped the company cooperate with relevant patient advocacy groups. As a result, client was able to create 5 age-tailored information booklets explaining CTs' aims and procedures.
Testimonials
“A great overview of state-of-the art PM in generic business. The discussions on topics from real experience with Dr. Ross were especially interesting given his broad area of expertise because it's all related!”Jiří Václavík
Project Manager, Zentiva
“It was a good overview on Project Management tools and skills. A good starting point for PM implementation.”Catarina Estevens
Project Manager Pharmaceutical, Development Tecnimede
“Very rich content with real world examples. Trainer is very strong in rich information/right content. Worth to take this training if your routes cross VAM development.”Araksya Topchyan
Global Marketing Manager Pharma, DSM
Clients that have benefited from our courses
